Tick-Borne Disease Working Group
January 28-29, 2020, TBDWG Meeting (in-person)
Back to Tick-Borne Disease Working Group Meetings
January 28-29, 2020, TBDWG Meeting (in-person)
January 28, 2020 - January 29, 2020
Agenda
Day 1 - January 28, 2020
TIME | AGENDA ITEM | SPEAKERS |
---|---|---|
8:30 am - 8:40 am | Welcome Remarks | Admiral Brett Giroir |
8:40 am – 8:45 am | - Welcome from the Working Group - Roll Call: During roll call members are asked to state their organization and what subcommittee(s) they co-chair | Leigh Ann Soltysiak, Co-Chair David Walker, Co-Chair Jim Berger, DFO |
8:45 am – 8:47 am | Overview of the Working Group’s Mission, Vision Statement, Values | Jim Berger, DFO |
8:47 am – 8:57 am | - Update from September 12, 2019, Meeting to Today - Review 2020 TBDWG objectives - What We Hope to Accomplish Today - Introduction of Speakers | Leigh Ann Soltysiak, Co-Chair David Walker, Co-Chair |
8:57 am – 9:02 am | - NIH Strategic Plan Update - CDC-led Domestic Framework - FDA update on Tick-Borne and Vector-Borne diseases | Sam Perdue, NIH Ben Beard, CDC Todd Myers, FDA |
9:02 am – 9:32 am | Public Comments | - |
9:32 am – 9:42 am | Public Comment Subcommittee Update - Comments received - Overall themes | Scott Commins, Co-Chair Angel Davey, Co-Chair Leigh Ann Soltysiak, Co-Chair |
9:42 am – 10:42 am | Subcommittee Presentation - Tick Biology, Ecology, and Control Subcommittee | Kevin Macaluso, Co-Chair Beto Perez de Leon, Co-Chair |
10:42 am – 11:00 am | Break | - |
11:00 am – 12:00 pm | Subcommittee Presentation - Pathogenesis and Physiology of Lyme Disease Subcommittee | Sam Donta, Co-Chair Leith States, Co-Chair |
12:00 pm – 1:00 pm | Subcommittee Presentation - Clinical Aspects of Lyme Disease Subcommittee | Scott Cooper, Alt. CMS Rep. Sam Donta, Co-Chair |
1:00 pm – 2:00 pm | Lunch | - |
2:00 pm – 3:00 pm | Subcommittee Presentation – Training, Education, Access to Care, and Reimbursement Subcommittee | Betty Maloney, Co-Chair Pat Smith, Co-Chair |
3:00 pm – 4:00 pm | Subcommittee Presentation - Alpha-gal Subcommittee | Scott Commins, Co-Chair Angel Davey, Co-Chair Leigh Ann Soltysiak, Co-Chair |
4:00 pm | Adjourn | - |
Day 2 - January 29, 2020
Time | Agenda Item | Speaker |
---|---|---|
9:00 am – 9:05 am | Welcome from the Working Group | Leigh Ann Soltysiak, Co-Chair David Walker, Co-Chair |
9:05 am – 9:07 am | Recap of First Day | Jim Berger, DFO |
9:07 am – 9:37 am | Public Comments | - |
9:37 am – 10:37 am | Subcommittee Presentation - Babesiosis and Tick-Borne Pathogens Subcommittee | Ben Beard, Co-Chair Gene Shapiro, Co-Chair |
10:37 am – 10:52 am | Break | - |
10:52 am – 11:52 am | Subcommittee Presentation - Ehrlichiosis and Anaplasmosis Subcommittee | Dennis Dixon, Co-Chair David Walker, Co-Chair |
11:52 am – 12:52 pm | Subcommittee Presentation - Rickettsiosis Subcommittee | Estella Jones, Co-Chair David Walker, Co-Chair |
12:52 pm – 1:52 pm | Lunch | - |
1:52 pm – 1:57 pm | Federal Inventory Update - What has been received - What is outstanding | Jim Berger, DFO |
1:57 pm – 3:07 pm | Open Discussions for Working Group | Working Group |
3:07 pm – 3:22 pm | Break | - |
3:22 pm – 3:52 pm | Discussion of Next Steps and What is Expected for the March Meeting | Leigh Ann Soltysiak, Co-Chair David Walker, Co-Chair |
3:52 pm – 3:57 pm | Review Draft Outline of Report to Congress | Working Group |
3:57 pm – 4:30 pm | Open Discussion for Working Group | Working Group |
4:30 pm | Adjourn | - |
The 11th meeting of the Tick-borne Disease Working Group was held at the Hyatt Place Washington DC/US Capitol, Washington, DC.
For this meeting, the Working Group 1) heard presentations from eight subcommittees on their findings and potential actions for the TBDWG to consider; 2) heard updates from the Public Comment and Inventory Subcommittees; and 3) further discussed plans for developing the 2020 report to Congress on federal tick-borne activities and research.
Meeting Webcast (pending)
If you would like the meeting slide presentations for Day 1 and/or Day 2, please send your request to tickbornedisease@hhs.gov.
Content created by Office of Infectious Disease and HIV/AIDS Policy (OIDP)
Content last reviewed January 7, 2022